In contrast to cocaine, prenatal exposure to methadone does not produce detectable alterations in the developing mouse brain

Developmental Brain Research

Volumn 110, Issue 1, 1998, Pages 61-67

  Nassogne, Marie Cécile ^a,b,d   Gressens, Pierre ^c   Evrard, Philippe ^c   Courtoy, Pierre J ^a  

^a DE DUVE INSTITUTE   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c HÔPITAL ROBERT DEBRÉ   (France)

^d Cell Biology Unit   (Belgium)

Author keywords

Cocaine; Methadone; Neurodevelopment; Neuron; Teratology

Indexed keywords

COCAINE; METHADONE;

ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; DRUG ABUSE; INTRAUTERINE GROWTH RETARDATION; MOUSE; NEUROTOXICITY; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; TERATOGENICITY;

ANIMALIA;

EID: 0032504934     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(98)00094-7     Document Type: Article

References (28)

1. G. Blinick, R.C. Wallach, E. Jerez, B.D. Ackerman, Drug addiction in pregnancy and the neonate, Am. J. Obstet. Gynecol. 125 (1976) 135-142.
2. M.M. de Cubas, T. Field, Children of methadone-dependent women: developmental outcomes, Am. J. Orthopsychiatr. 63 (1993) 266-276.
3. T.M. Doberczak, S.R. Kandall, P. Friedmann, Relationship between maternal methadone dosage, maternal-neonatal methadone levels, and neonatal withdrawal, Obstet. Gynecol. 81 (1993) 936-940.
4. T.M. Doberczak, J.C. Thornton, J. Bernstein, S.R. Kandall, Impact of maternal drug dependency on birth weight and head circumference of offspring, Am. J. Dis. Child. 141 (1987) 1163-1167.
5. D.H. Ford, R.K. Rhines, Prenatal exposure to methadone HCl in relationship to body and brain growth in the rat, Acta Neurol. Scand. 59 (1979) 248-262.
6. P. Gressens, B.E. Kosofsky, P. Evrard, Cocaine-induced disturbances of corticogenesis in the developing murine brain, Neurosci. Lett. 140 (1991) 113-116.
7. P. Gressens, C. Richelme, H.J. Khadim, J.F. Gadisseux, P. Evrard, The germinative zone produces most cortical astrocytes after neuronal migration in the developing mammalian brain, Biol. Neonate 61 (1992) 4-24.
8. S.L. Hans, Developmental consequences of prenatal exposure to methadone, Ann. NY Acad. Sci. 562 (1989) 195-207.
9. R.G. Harper, G. Solish, E. Feingold, N.B. Gersten-Woolf, M.M. Sokal, Maternal ingested methadone, body fluid methadone, and the neonatal withdrawal syndrome, Am. J. Obstet. Gynecol. 129 (1977) 417-424.
10. K.A. Kaltenbach, Effects of in-utero opiate exposure: new paradigms for old questions, Drug Alcohol Depend. 36 (1994) 83-87.
11. S.R. Kandall, S. Albin, J. Lowinson, B. Berle, A.J. Eidelman, L.M. Gartner, Differential effect of maternal heroin and methadone use on birth weight, Pediatrics 58 (1976) 681-685.
12. B.E. Kosofsky, A.S. Wilkins, P. Gressens, P. Evrard, Transplacental cocaine exposure: a mouse model demonstrating neuroanatomic and behavioral abnormalities, J. Child Neurol. 9 (1994) 234-241.
13. M.S. Lidow, Prenatal cocaine exposure adversely effects development of the primate cerebral cortex, Synapse 21 (1995) 332-341.
14. M.H. Lifschitz, G.S. Wilson, E.O. Smith, M.M. Desmond, Fetal and postnatal growth of children born to narcotic-dependent women, J. Pediatr. 102 (1983) 686-691.
15. O.H. Lowry, N.J. Rosenbrough, A.L. Farr, R.J. Randall, Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193 (1951) 265-275.
16. J.K. Markham, J.L. Emmerson, N.V. Owen, Teratogenicity studies of methadone-HCl in rats and rabbits, Nature 233 (1971) 342-343.
17. M.C. Nassogne, P. Evrard, P.J. Courtoy, Selective direct toxicity of cocaine on fetal mouse neurons: teratogenic implications of neurite and apoptotic neuronal loss, Ann. NY Acad. Sci. 846 (1998) 51-68.
18. M.C. Nassogne, P. Evrard, P.J. Courtoy, Selective neuronal toxicity of cocaine in embryonic mouse brain co-cultures, Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 11029-11033.
19. M.C. Nassogne, J. Louahed, P. Evrard, P.J. Courtoy, Cocaine induces apoptosis in cortical neurons of fetal mice, J. Neurochem. 68 (1997) 2442-2450.
20. M.A. Peters, The effect of maternally administered methadone on brain development in the offspring, J. Pharmacol. Exp. Ther. 203 (1977) 340-346.
21. S.E. Robinson, H. Guo, R.F. Spencer, Prenatal exposure to methadone delays the development of striatal cholinergic neurons, Dev. Brain Res. 76 (1993) 239-248.
22. M.E. Strauss, M. Andresko, J.C. Stryker, J.N. Wardell, L.D. Dunkel, Methadone maintenance during pregnancy: pregnancy, birth, and neonate characteristics, Am. J. Obstet. Gynecol. 120 (1974) 895-900.
23. N. Swan, Research demonstrates long-term benefits of methadone treatment, NIDA Notes 1 (1994) 4-5.
24. J.J. Volpe, Effect of cocaine use on the fetus, New Engl. J. Med. 327 (1992) 399-407.
25. G.S. Wilson, M.M. Desmond, R.B. Wait, Follow-up of methadone-treated and untreated narcotic-dependent women and their infants: health, developmental, and social implications, J. Pediatr. 98 (1981) 716-722.
26. D. Zachor, J.K. Cherkes, C.T. Fay, I. Ocrant, Cocaine differentially inhibits neuronal differentiation and proliferation in vitro, J. Clin. Invest. 93 (1994) 1179-1185.
27. I.S. Zagon, P.J. McLaughlin, Neuronal cell deficits following maternal exposure to methadone in rats, Experientia 38 (1982) 1214-1216.
28. I.S. Zagon, P.J. McLaughlin, Perinatal methadone exposure and brain development: a biochemical study, J. Neurochem. 31 (1978) 49-54.